This study tests whether constitutional genetic variants in matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) genes are associated with outcome of GEJ adenocarcinoma. The gene discussed is TIMP1; the disease is gastroesophageal junction adenocarcinoma.